Are patients willing to be informed on the risks and complications associated with the proposed therapy? A survey on informed consent.

Aigli DafniPanagoula OikonomouKonstantinos Anagnostopoulos Christos TsalikidisNigyar DzhaferAlexandra K TsarouchaMichail Pitiakoudis

Published in: Folia medica (2022)

Patients want to be informed about their treatment options and possible complications so that they can make decisions about their treatment after a comprehensive and understandable discussion.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
risk factors
stem cells
patient reported outcomes
mesenchymal stem cells
bone marrow
climate change